The impact of insulin requirement on mortality and morbidity in non-diabetic covid-19 patients in the intensive care unit: A retrospective, observational study
Insulin requirement in non-diabetic COVID-19 ICU patients is a predictor of 6-month mortality. High-dose corticosteroids exacerbate glycemic dysregulation, increasing insulin needs. SARS-CoV-2-induced beta-cell damage and hyperinflammation-related stress hyperglycemia elevate the risk of post-discharge DM. Close monitoring and diabetes screening are essential in this population.
Authors
- Kadir Yeşildal (ORCID: https://orcid.org/0000-0002-3523-4240)
- Namigar Turgut (ORCID: https://orcid.org/0000-0003-0252-3377)
- Müslüm Akkılıç (ORCID: https://orcid.org/0000-0003-1883-708X)
- Fethi Gültop (ORCID: https://orcid.org/0000-0002-1206-2765)
- Cansu Kılınç Berktaş (ORCID: https://orcid.org/0000-0002-5387-0734)
Institutions
- Ministry of Health (TR)
- Türk Anesteziyoloji ve Reanimasyon Derneği (TR)
Publication Details
- Journal
- BMC Anesthesiology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1186/s12871-025-03037-7
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00